What is Vyome Holdings, Inc. (HIND) stock price today?

Vyome Holdings, Inc. (HIND) currently trades at $2.03 per share. The stock has a market capitalization of $15.09M and a P/E ratio of —x.

Is HIND stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Vyome Holdings, Inc. has a Smart Value Score of 14/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Vyome Holdings, Inc.'s revenue and earnings?

Vyome Holdings, Inc. has trailing twelve-month (TTM) revenue of $319710.00 with profit margins of 0.00%. Earnings per share (EPS) is $-4.86.

HIND

Vyome Holdings, Inc.

NASDAQ: HIND · HEALTHCARE · BIOTECHNOLOGY

$2.03

-0.49% today

Updated 2026-04-30

Market cap

$15.09M

P/E ratio

—

P/S ratio

47.20x

EPS (TTM)

$-4.86

Dividend yield

—

52W range

$2 – $56

Volume

0.0M

Market cap

$15.09M

P/E ratio

—

P/S ratio

47.20x

EPS (TTM)

$-4.86

Dividend yield

—

52W range

$2 – $56

Volume

0.0M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

2.7

Growth

5.0

Quality

C+

3.0

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$15.00

+638.92%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

1 Strong Buy0 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-1.48M

- Revenue declining -40.50% QoQ

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$11.24M	$8.68M	$8.01M	$319714.00	$319710.00
Net income	$-46.21M	$-11.39M	$-7.13M	$-10.26M	$-1.23M
EPS	—	—	—	—	$-4.86
Free cash flow	$-22.03M	$-17.00M	$-4.43M	$-3.75M	$-1.48M
Profit margin	-411.16%	-131.22%	-89.06%	-3,209.75%	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
HIND	$15.09M	14	2.7	3.0	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Vyome Holdings, Inc. trades at $2.03. Our Smart Value Score of 14/100 indicates the stock is weak. TTM revenue stands at $319710.00.

Frequently asked questions

What is Vyome Holdings, Inc.'s stock price?

Vyome Holdings, Inc. (HIND) trades at $2.03.

Is Vyome Holdings, Inc. overvalued?

Smart Value Score 14/100 (Grade F, Strong Sell).

What is the price target of Vyome Holdings, Inc. (HIND)?

The analyst target price is $15.00, representing +638.9% upside from the current price of $2.03.

What is Vyome Holdings, Inc.'s revenue?

TTM revenue is $319710.00.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio47.20x

ROE—

Beta—

50D MA$2.48

200D MA$5.25

Shares out0.01B

Float0.00B

Short ratio—

Avg volume0.0M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

HIND vs LLY →HIND vs JNJ →HIND vs ABBV →Stock screener →